hCAIX-IN-10 is a selective inhibitor of carbonic anhydrase IX and XII (hCAIX and hCAXII), with Ki values of 61.5 nM and 586.8 nM, respectively; it targets transmembrane carbonic anhydrase isoforms that serve as biomarkers for certain types of tumors and are involved in maintaining acid-base homeostasis in both normal and cancer cells.